Literature DB >> 2512694

A large-sample study of diazepam pharmacokinetics.

D J Greenblatt1, J S Harmatz, H Friedman, A Locniskar, R I Shader.   

Abstract

Healthy male volunteers (n = 48) aged 18-44 years received a single 10-mg oral dose of diazepam. Plasma diazepam and desmethyldiazepam concentrations were measured at multiple points during the next 11 days. The distribution of peak plasma concentration (mean, 406 ng/ml) was not skewed and did not differ significantly from normal (Guassian). However, the distributions of elimination half-life (44.2 h), elimination rate constant (0.0219/h), clearance (26.6 ml/min), and volume of distribution (83 L) all were significantly skewed and deviated significantly fron normal. After logarithmic transformation, the distributions of elimination rate constant, elimination half-life, and volume of distribution were consistent with normal; however, this was not the case for time of peak plasma concentration. Thus, the pharmacokinetic characteristics of oral diazepam are highly variable even in a relatively homogeneous population. Parametric statistical testing procedures and pharmacokinetic forecasting schemes may be improved by more precise delineation of the underlying distributions for pharmacokinetic variables.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2512694     DOI: 10.1097/00007691-198911000-00007

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  9 in total

Review 1.  Comparative tolerability of sedative agents in head-injured adults.

Authors:  Susan C Urwin; David K Menon
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 2.  Pharmacokinetic optimisation of antiemetic therapy.

Authors:  M Campbell; D N Bateman
Journal:  Clin Pharmacokinet       Date:  1992-08       Impact factor: 6.447

3.  Variability and singularity arising from poor compliance in a pharmacokinetic model I: the multi-IV case.

Authors:  Pierre-Emmanuel Lévy Véhel; Jacques Lévy Véhel
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-12-30       Impact factor: 2.745

4.  Variability and singularity arising from a Piecewise-Deterministic Markov Process applied to model poor patient compliance in the multi-IV case.

Authors:  Lisandro J Fermín; Jacques Lévy-Véhel
Journal:  J Appl Stat       Date:  2020-01-07       Impact factor: 1.416

5.  Subjective and behavioral effects of diazepam depend on its rate of onset.

Authors:  H de Wit; S Dudish; J Ambre
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 6.  Clinical pharmacokinetics of alprazolam. Therapeutic implications.

Authors:  D J Greenblatt; C E Wright
Journal:  Clin Pharmacokinet       Date:  1993-06       Impact factor: 6.447

Review 7.  Current State of Analgesia and Sedation in the Pediatric Intensive Care Unit.

Authors:  Chinyere Egbuta; Keira P Mason
Journal:  J Clin Med       Date:  2021-04-23       Impact factor: 4.241

8.  Intentional Hydroxychloroquine Overdose Treated with High-Dose Diazepam: an Increasing Concern in the COVID-19 Pandemic.

Authors:  Peter R Chai; E G Ferro; J M Kirshenbaum; B D Hayes; S E Culbreth; E W Boyer; T B Erickson
Journal:  J Med Toxicol       Date:  2020-06-08

9.  An explorative approach to understanding individual differences in driving performance and neurocognition in long-term benzodiazepine users.

Authors:  Frederick R J Vinckenbosch; Annemiek Vermeeren; Eric F P M Vuurman; Nick N J J M van der Sluiszen; Joris C Verster; Aurora J A E van de Loo; Joke H van Dijken; Janet L Veldstra; Karel A Brookhuis; Dick De Waard; Johannes G Ramaekers
Journal:  Hum Psychopharmacol       Date:  2021-02-06       Impact factor: 1.672

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.